Back
Novo Nordisk AS Stock Price Chart

Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
50
NONOF
Novo Nordisk AS
Last Price:
$70.46
Seasonality Move:
5.06%
7 Day Trial
ALL ACCESS PASS
$
7

Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing slight selling pressure.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 68.69 | Buy |
20-day SMA: | 66.85 | Buy |
50-day SMA: | 66.16 | Buy |
200-day SMA: | 95.16 | Sell |
8-day EMA: | 68.94 | Buy |
20-day EMA: | 67.42 | Buy |
50-day EMA: | 69.01 | Buy |
200-day EMA: | 88.41 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.95 | Buy |
Relative Strength Index (14 RSI): | 57.15 | Buy |
Chaikin Money Flow: | -8957 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.32 - 69) | Buy |
Bollinger Bands (100): | (65.31 - 84.61) | Sell |
Novo Nordisk AS Technical Analysis
May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 70.51 while NONOF 8-day simple moving average is 68.69, which is a Buy signal.
-
The stock price of NONOF is 70.51 while Novo Nordisk AS 20-day SMA is 66.85, which makes it a Buy.
-
Novo Nordisk AS 50-day simple moving average is 66.16 while NONOF share price is 70.51, making it a Buy technically.
-
NONOF stock price is 70.51 and Novo Nordisk AS 200-day simple moving average is 95.16, creating a Sell signal.
NONOF Technical Analysis vs Fundamental Analysis
Sell
50
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NONOF] share price is $70.51. The Score for NONOF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
313.3B
Price in USD:
70.51
Share Volume:
47.1K
Novo Nordisk AS 52-Week Range
52-Week High:
149.55
52-Week Low:
55.28
Sell
50
Novo Nordisk AS (NONOF)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 70.51 USD today.
-
Will NONOF stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 70.51 while NONOF 8-day exponential moving average is 68.94, which is a Buy signal.
-
The stock price of NONOF is 70.51 while Novo Nordisk AS 20-day EMA is 67.42, which makes it a Buy.
-
Novo Nordisk AS 50-day exponential moving average is 69.01 while NONOF share price is 70.51, making it a Buy technically.
-
NONOF stock price is 70.51 and Novo Nordisk AS 200-day simple moving average is 88.41, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NONOF Moving Average Covergence Divergence (MACD) indicator is 0.95, suggesting Novo Nordisk AS is a Buy
-
Novo Nordisk AS Relative Strength Index (RSI) is 57.15, which suggest Novo Nordisk AS is overbought
-
The Bollinger Bands (25) for Novo Nordisk AS is (64.32 - 69), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (65.31 - 84.61), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.